Recombinant UBE3A Monoklonale Antilichaam
Gecertificeerd

Recombinant UBE3A Monoklonale Antilichaam

Catalog #: AN302038L-01
Maat: 50 µL

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Background

UBE3A, also commonly referred to as E6AP (E6 Associated Protein), is an E3 ubiquitin protein ligase and founding member of the HECT (Homologous to the E6 Carboxyl Terminus) family of E3 ligases. UBE3A has been shown to be hijacked by the oncogenic E6 protein of high-risk human papillomaviruses (HPV16 and HPV18) that causes the ubiquitination activity of UBE3A to be inappropriately directed toward several specific cellular proteins, the most notable of which, with respect to carcinogenesis, is p53. Although the DNA-repair enzyme, HHR23A (human homolog A of Rad23), was the first described E6-independent substrate of UBE3A, very few E6-independent targets of UBE3A have been identified. This continues to be an active area of research, particularly because mutations or disruption in expression of UBE3A in the brain are the cause of Angelman syndrome (AS), a severe form of mental retardation. Although UBE3A is expressed in most human tissues from both parental alleles, it is expressed from the maternal allele in subregions of the brain, with the paternal allele being epigenetically silenced. AS is caused by disruptions in expression of the materal UBE3A allele, generally by large chromosomal deletion, but also by point mutations within the UBE3A coding sequence. This strongly suggests that lack of ubiquitination of one or more UBE3A substrates in neuronal tissue is responsible for the AS phenotype. Indeed, a recent study identified several new neuronal substrates of UBE3A including Arc and Ephexin-5. The immediate early gene Arc (activity-regulated cytoskeleton-associated protein) is rapidly upregulated after robust neuronal stimulation and promotes internalization of AMPA-type glutamate receptors (AMPARs), resulting in reduction in synaptic strength. UBE3A ubiquitinates Arc and promotes its degradation by the 26S proteasome, thus preventing AMPAR internalization. Disruption in neuronal UBE3A function leads to an increase in Arc expression and a decrease in AMPARs at excitatory synapses, which may contribute to the neurological symptoms of AS.

Abbreviation

UBE3A

UniProt

Q05086

Host

• Rabbit

Reactivity

Human

Immunogen

Peptide. This information is proprietary to PTMab.

Target

UBE3A; ANCR; AS; E6-AP; EPVE6AP; HPVE6A; E6AP; ubiquitin protein ligase E3A

Clonality

• Monoclonal

• Recombinant

Clone

A758

Conjugation

Unconjugated

Applications

WB

Field of Research

Epigenetics and Nuclear Signaling; Cell Biology; Neuroscience

Purification

Protein A purified

Concentration

1 mg/mL

Dilution

WB 1:5000

Buffer

PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

Shipping Conditions

Ice bag

Storage Conditions

Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Product MSDS

https://789.bio/eb/hWIkNcN1

Calculated Molecular Weight

101 kDa

Observed Molecular Weight

95 kDa

Isotype

IgG, κ

Beschrijving

Recombinant UBE3A Monoklonale Antilichaam Beschikbaar in 50 µL. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamRecombinant UBE3A Monoklonale Antilichaam
Categorie
Beschikbare grootte50 µL
CatalogusnummerAN302038L-01